Aclarion (NASDAQ:ACON – Get Free Report) and ACI Global (OTCMKTS:ACGJ – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, risk, profitability, valuation, analyst recommendations, dividends and institutional ownership.
Earnings and Valuation
This table compares Aclarion and ACI Global’s revenue, earnings per share and valuation.
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
Aclarion | $60,048.00 | 38.35 | -$4.91 million | N/A | N/A |
ACI Global | N/A | N/A | N/A | N/A | N/A |
ACI Global has lower revenue, but higher earnings than Aclarion.
Analyst Ratings
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Aclarion | 0 | 0 | 1 | 0 | 3.00 |
ACI Global | 0 | 0 | 0 | 0 | N/A |
Aclarion presently has a consensus target price of $1.60, suggesting a potential upside of 470.00%.
Risk & Volatility
Aclarion has a beta of 0.47, meaning that its stock price is 53% less volatile than the S&P 500. Comparatively, ACI Global has a beta of 2.12, meaning that its stock price is 112% more volatile than the S&P 500.
Insider & Institutional Ownership
7.5% of Aclarion shares are held by institutional investors. 22.3% of Aclarion shares are held by insiders. Comparatively, 25.9% of ACI Global shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Profitability
This table compares Aclarion and ACI Global’s net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
Aclarion | -10,246.33% | -2,554.98% | -251.78% |
ACI Global | N/A | N/A | N/A |
Summary
ACI Global beats Aclarion on 5 of the 8 factors compared between the two stocks.
About Aclarion
Aclarion, Inc., a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. It develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was incorporated in 2008 and is based in Broomfield, Colorado.
About ACI Global
ACI Global Corporation, a development stage company, through its subsidiaries, engages in the design and development of proprietary technology for the production of synthetic rubber powder and thermoplastic elastomers under Micropowder trade name in the United States. It intends to utilize Micropowder technology in its chemical composition and for the manufacture of rubber and elastomers that are used in tire plastic industries. ACI Global was founded in 1997 and is based in Greenwich, Connecticut.
Receive News & Ratings for Aclarion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aclarion and related companies with MarketBeat.com's FREE daily email newsletter.